ACSL3 overexpression increased cell proliferation, migration, and invasion altering the metabolic properties of lung cancer cells and was associated with worse clinical outcomes in patients with high-grade NSCLC (Fernandez et al., 2020). The gene discussed is ACSL3; the disease is lung carcinoma.